Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Journal of Diabetes Investigation
|
February 15, 2023
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study
Naoki Sakane, Yushi Hirota, Akane Yamamoto, et al.
BMC Developmental Biology
|
August 10, 2010
Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in mice
Ediriweera P S Chandana, Yasuhiro Maeda, Akihiko Ueda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2023
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial
Tadaaki Nishikawa, Kosei Hasegawa, Koji Matsumoto, et al.
Blood Advances
|
May 20, 2026
Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trial
Shinichi Makita, Junji Koya, Yasuhiro Suzuki, et al.
Diabetology International
|
January 29, 2025
Cost-effective analysis focused on hypoglycemia of intermittent-scanning continuous glucose monitoring in type 1 diabetes adults: a ISCHIA randomized clinical trial
Naoki Sakane, Munehide Matsuhisa, Akio Kuroda, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
September 3, 2017
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Cardiovascular Diabetology
|
January 5, 2021
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
August 6, 2021
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Cardiovascular Diabetology
|
July 11, 2020
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Cardiovascular Diabetology
|
June 22, 2023
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Journal of Diabetes Investigation
|
February 15, 2023
Factors associated with hemoglobin glycation index in adults with type 1 diabetes mellitus: The FGM-Japan study
Naoki Sakane, Yushi Hirota, Akane Yamamoto, et al.
BMC Developmental Biology
|
August 10, 2010
Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in mice
Ediriweera P S Chandana, Yasuhiro Maeda, Akihiko Ueda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 28, 2023
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial
Tadaaki Nishikawa, Kosei Hasegawa, Koji Matsumoto, et al.
Blood Advances
|
May 20, 2026
Atezolizumab for relapsed/refractory extranodal NK/T-cell lymphoma: the phase II NCCH1903/ATTACK trial
Shinichi Makita, Junji Koya, Yasuhiro Suzuki, et al.
Diabetology International
|
January 29, 2025
Cost-effective analysis focused on hypoglycemia of intermittent-scanning continuous glucose monitoring in type 1 diabetes adults: a ISCHIA randomized clinical trial
Naoki Sakane, Munehide Matsuhisa, Akio Kuroda, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
September 3, 2017
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Cardiovascular Diabetology
|
January 5, 2021
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
August 6, 2021
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Cardiovascular Diabetology
|
July 11, 2020
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Cardiovascular Diabetology
|
June 22, 2023
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, et al.
Page
of 5